No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
NRXPW NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM)
- 0.2990
- +0.0690+30.00%
Close Jan 17 16:00 ET
0.3100High0.2000Low
0.3100High0.2000Low15.13KVolume0.2200Open0.2300Pre Close3.92KTurnover0.00%Turnover Ratio--P/E (Static)0Shares0.500052wk High--P/B0Float Cap0.039352wk Low--Dividend TTM0Shs Float16.1000Historical High--Div YieldTTM47.83%Amplitude0.0393Historical Low0.2590Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
News
8-K: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update
10-Q: Q3 2024 Earnings Report
8-K: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
10-Q: Q2 2024 Earnings Report
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed With Two New Drug Applications in 2024; NRX-101 Has Been Returned to the Company for Filing
8-K: NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update